Bedside hyperspectral imaging for the evaluation of microcirculatory alterations in perioperative intensive care medicine: a study protocol for an observational clinical pilot study (HySpI-ICU)
Open Access
- 17 September 2020
- Vol. 10 (9), e035742
- https://doi.org/10.1136/bmjopen-2019-035742
Abstract
Introduction Normalisation of macrocirculatory parameters during resuscitation therapy does not guarantee the restoration of microcirculatory perfusion in critical illness due to haemodynamic incoherence. Persistent microcirculatory abnormalities are associated with severity of organ dysfunction and mandate the development of bedside microcirculatory monitoring. A novel hyperspectral imaging (HSI) system can visualise changes in skin perfusion, oxygenation and water content at the bedside. We aim to evaluate the effectiveness of HSI for bedside monitoring of skin microcirculation and the association of HSI parameters with organ dysfunction in patients with sepsis and major abdominal surgery. Methods and analysis Three independent groups will be assessed and separately analysed within a clinical prospective observational study: (1) 25 patients with sepsis or septic shock (according to sepsis-3 criteria), (2) 25 patients undergoing pancreatic surgery and (3) 25 healthy controls. Patients with sepsis and patients undergoing pancreatic surgery will receive standard therapy according to local protocols derived from international guidelines. In addition, cardiac output of perioperative patients and patients with sepsis will be measured. Healthy controls undergo one standardised evaluation. The TIVITA Tissue System is a novel HSI system that uses the visible and near-infrared spectral light region to determine tissue microcirculatory parameters. HSI analysis (hand/knee) will be done in parallel to haemodynamic monitoring within defined intervals during a 72-hour observation period. HSI data will be correlated with the Sequential Organ Failure Assessment score, global haemodynamics, inflammation and glycocalyx markers, surgical complications and 30-day outcome. Ethics and dissemination The protocol has been approved by the local ethics committee of the University of Heidelberg (S-148/2019). Study results will be submitted to peer-reviewed journals and medical conferences. Trial registration number DRKS00017313; Pre-results.Keywords
This publication has 23 references indexed in Scilit:
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)Jama-Journal Of The American Medical Association, 2016
- Hemodynamic coherence and the rationale for monitoring the microcirculationCritical Care, 2015
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingEuropean Heart Journal – Cardiovascular Imaging, 2015
- Reduced Serum Butyrylcholinesterase Activity Indicates Severe Systemic Inflammation in Critically Ill PatientsMediators of Inflammation, 2015
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studiesInternational Journal of Surgery, 2014
- Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care MedicineIntensive Care Medicine, 2014
- World Medical Association Declaration of HelsinkiJama-Journal Of The American Medical Association, 2013
- Microcirculatory Alterations in Patients With Severe SepsisCritical Care Medicine, 2013
- Sepsis-Induced Degradation of Endothelial GlycocalixThe Scientific World Journal, 2010
- Clinical review: A review and analysis of heart rate variability and the diagnosis and prognosis of infectionCritical Care, 2009